Intravascular ultrasound is a new imaging technique
with the unique ability to study vessel wall morphology in vivo.1-5 In vitro and in vivo studies have demonstrated the accuracy and reproducibility of the method to measure vessel lumen dimensions and delineate wall morphology. [5] [6] [7] Other studies have shown the ability of intravascular imaging to assess vascular responses to pharmacological stimuli8 and to evaluate the acute success of mechanical interventions such as balloon angioplasty, stent placement, and atherectomy.9-11 Intracoronary ultrasound detects measurable intimal proliferation and atheroma formation before angiographic evidence of coronary artery disease.2 There- fore, it may be a powerful and sensitive method for serially evaluating and quantifying progression and/or regression of coronary artery disease. However, concern has been raised regarding catheter-induced endothelial damage leading to acceleration of the atherosclerotic process in instrumented vessels. The safety of the method must be demonstrated before this invasive imaging technique can be used routinely to serially follow patients who do not undergo therapeutic coronary interventions.
Cardiac transplant recipients at Stanford University undergo annual coronary angiography as part of an ongoing program monitoring for otherwise silent coronary disease. 13 Intracoronary ultrasound has been performed in these patients, with informed consent, at the time of the annual angiograms since July 1990. 12 The purpose of the present study was to assess both the immediate effects and safety of intracoronary ultrasound and the effect, if 
Procedural Observations and Acute Complications
The 240 intracoronary ultrasound studies were performed in 170 patients without any significant clinical or angiographic acute complications. Twenty patients had angiographically evident coronary spasm. In all of these cases, the spasm was shown angiographically as an area of sudden luminal narrowing, successfully reversed with intracoronary nitroglycerin. In no case was flow totally occluded by the spasm. In 2 of these 20 patients, the spasm was associated with ST-segment elevation during intracoronary ultrasound imaging. In 1 of these 2 patients, the procedure was stopped before imaging was completed, with immediate return of the ST-segment to baseline as soon as the imaging catheter was pulled out of the coronary artery, and no other complications were noted. In the other patient, the ST-segment returned to baseline after nitroglycerin, and the study was completed without incident. Ten of these 20 patients were studied within 1 month after transplantation, and all had evidence of intimal thickening by ultrasound. The other 10 patients with spasm, studied more remotely from transplantation, all had increased intimal thickening by ultrasound, and 2 also had coronary artery disease by angiography. No other complications were noted; specifically, there were no instances of coronary dissection noted by angiography or intracoronary ultrasound.
One-Year Assessment
The change in absolute diameter in the 49 imaged vessels was -0.11+0.28 mm versus a change of -0.07±0.22 mm in the 61 nonimaged vessels (P=.49). The percentage change in diameter of the imaged vessels was -5+11% versus -3+7% in the nonimaged vessels (P=.32). Three patients had angiographic evidence of transplant coronary artery disease on their initial angiogram represented by either distal small vessel disease or proximal discrete lesions.16 These three patients did not demonstrate accelerated angiographic narrowing of their imaged vessels when compared with their nonimaged vessels on their follow-up study (-0.21 mm vs -0.23 mm and -11% vs -9%). Seven patients had greater than 500 ,um of mean circumferential intimal thickness measured by intravascular ultrasound in their proximal left anterior descending or left circumflex coronary arteries on their initial ultrasound study but no angiographically evident coronary artery disease, ie, angiographically silent intimal thickening. This subgroup of patients also had no increased narrowing of their imaged arteries compared with their nonimaged vessels (-0.16+0.3 mm vs -0.8+0.17 mm, P=.6, and -6+12% vs -2+5%, P=.5). See Table and Figure. The results of serial intravascular ultrasound evaluating progression of intimal proliferation will be reported separately.
Discussion
Serial computer-assisted quantitative angiography is presently the most accessible, well-validated technique that can readily survey the entire coronary vascular system and allow quantification of coronary artery disease progression and regression. Intracoronary ultrasound has the ability to detect intimal proliferation before angiographic evidence of disease and therefore offers a unique potential to study atheromatous coronary artery disease progression and regression. However, the safety of this imaging technique must be validated before it will be readily accepted for use in vessels not undergoing coronary interventions. In particular, these issues need to be resolved if intracoronary ultrasound is to be used as a tool to assess progression or regression of coronary artery disease.
Cardiac transplant recipient studied at 3 weeks (A, C) and 1 year after transplantation (B, D). There is a diffuse decrease in luminal size involving the three major epicardial vessels. The left anterior descending artery (upper right, A and B) was the vessel instrumented for intracoronary ultrasound imaging.
The acute clinical safety of intracoronary ultrasound has been demonstrated in a previous publication describing intracoronary studies performed in 80 cardiac transplant recipients without any significant complications.12 This is further supported in the present study. Although 20 patients had angiographic evidence of coronary spasm, despite pretreatment with nitroglycerin, this was easily reversed by intracoronary nitroglycerin. Only one study had to be interrupted because of ST-segment elevation. In The present study shows no significant difference between the instrumented and noninstrumented vessels regarding angiographically detectable luminal narrowing. It also shows a lack of significant impact of the intervention, both in subgroups of patients who initially had angiographic evidence of coronary disease and in those with ultrasound evidence of intimal thickening but without angiographic evidence of coronary disease at the time of their first study.
It is possible the instrumentation of the coronary arteries did have some negative effect on the intima. Catheter abrasion of vessels is an established method for stimulating local atherogenesis.23'24 However, these results suggest the acceleration of the atherosclerotic process in this group of patients is mild and not discernable beyond the variability of the process within patients. This should reassure the patients and physicians participating in studies assessing this technique for various purposes, as it implies a negligible effect from the procedure itself. On the other hand, the fact that the disease process may have obscured effects of lumen instrumentation should be considered. These patients served as their own control, thus minimizing this possibility. The trend suggesting a reduction in luminal size in the imaged vessels is slight in this study, so very large numbers of vessels might be needed to establish a statistical difference between instrumented and noninstrumented vessels (ie, type II error). In the present study, only one type of ultrasound catheter was used, consisting of a single mechanically driven acoustic mirror and transducer. Other studies will be needed to evaluate complication rates among patients studied with different catheter configurations.
Intracoronary ultrasonic imaging is increasingly recognized for its ability to accurately display the details of vessel structure,5 but quantitative angiography is still used as the gold standard for monitoring progression of coronary artery disease. The coronary angiogram represents only a projectional image of the vessel lumen. Several comparative studies of angiography and pathology have demonstrated the shortcomings of angiography for estimation of atheromatous plaque.26-29 Understanding the limitations of angiography, it was obvious from the outset that angiography is an imperfect tool to answer the question of long-term safety addressed in this study. However, current technologies do not allow imaging or measurement of atheroma by other methods usable for this study. The limitations of angiography were minimized by using the patient as his/her own control and by routinely administering nitroglycerin to mitigate the effects of variable vascular tone. The present study does not address the question of possibly altered endothelial function after coronary instrumentation. However, absence of coronary artery diameter change is a reasonable and time-honored marker for coronary disease.
The potential overriding effect of the rate of acceleration of disease in this group of patients can only be addressed by comparison with a similar study in patients with native coronary artery disease. We are not aware patients were systematically heparinized to achieve ACT >300. Whether this degree of heparinization is necessary or not is uncertain. The present study shows that intravascular ultrasound is safe when used in large and medium-size coronary arteries, since we did not advance into vessels smaller than 2 mm because of the ultrasound catheter size.
These data suggest that intracoronary ultrasound is a safe and feasible imaging technique for the serial study of coronary artery disease in patients who are not undergoing therapeutic coronary interventional procedures.
